No I thought not. Another academic on the payroll. At least the manipulator at 1 cent will make money. Ordinary shareholders at or above 2c will be lucky to break-even.
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial